Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan:156:209212.
doi: 10.1016/j.josat.2023.209212. Epub 2023 Nov 5.

Implementation of an office-based addiction treatment model for Medicaid enrollees: A mixed methods study

Affiliations

Implementation of an office-based addiction treatment model for Medicaid enrollees: A mixed methods study

Peter Treitler et al. J Subst Use Addict Treat. 2024 Jan.

Abstract

Introduction: Medications for opioid use disorder (MOUD) are the most effective treatment for opioid use disorder (OUD) but remain underutilized. To reduce barriers to MOUD prescribing and increase treatment access, New Jersey's Medicaid program implemented the Office-Based Addiction Treatment (OBAT) Program in 2019, which increased reimbursement for office-based buprenorphine prescribing and established newly reimbursable patient navigation services in OBAT clinics. Using a mixed-methods design, this study aimed to describe stakeholder experiences with the OBAT program and to assess implementation and uptake of the program.

Methods: This study used a concurrent, triangulated mixed-methods design, which integrated complementary qualitative (semi-structured interviews) and quantitative (Medicaid claims) data to gain an in-depth understanding of the implementation of the OBAT program. We elicited stakeholder perspectives through interviews with 22 NJ Medicaid MOUD providers and 8 policy key informants, and examined trends in OBAT program utilization using 2019-2020 NJ Medicaid claims for 5380 Medicaid enrollees who used OBAT services. We used cross-case analysis (provider interviews) and a case study approach (key informant interviews) in analyzing qualitative data, and calculated descriptive statistics and trends for quantitative data.

Results: Provider enrollment and utilization of OBAT services increased steadily during the first two years of program implementation. Interviewees reported that enhanced reimbursements for office-based MOUD incentivized greater MOUD prescribing, while coverage of patient navigation services improved patient care. Despite increasing enrollment in the OBAT program, the proportion of primary care physicians in the state who enrolled in the program remained limited. Key barriers to enrollment included: requirements for a patient navigator; concerns about administrative burdens and reimbursement delays from Medicaid; lack of awareness of the program; and beliefs that patients with OUD were better served in comprehensive care settings. Patient navigation was highlighted as a critical and valuable element of the program, but navigator enrollment and reimbursement challenges may have prevented greater uptake of this service.

Conclusions: Implementation of an OBAT model that enhanced reimbursement and provided coverage for patient navigation likely expanded access to MOUD in NJ. Results support initiatives like the OBAT program in improving access to MOUD, but program adaptations, where feasible, could improve uptake and utilization.

Keywords: Medicaid; Medications for opioid use disorder; Mixed-methods; Office-based addiction treatment; Patient navigation.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors have no competing interests to report.

Similar articles

References

    1. Abraham R, Wilkinson E, Jabbarpour Y, Petterson S, & Bazemore A (2020). Characteristics of office-based buprenorphine prescribers for Medicare patients. Journal of the American Board of Family Medicine, 33(1), 9–16. 10.3122/jabfm.2020.01.190233 - DOI - PubMed
    1. Adams VJM, & Volkow ND (2020). Ethical imperatives to overcome stigma against people with substance use disorders. AMA Journal of Ethics, 22(8), 702–708. 10.1001/amajethics.2020.702 - DOI - PubMed
    1. Ali-Faisal SF, Colella TJF, Medina-Jaudes N, & Benz Scott L (2017). The effectiveness of patient navigation to improve healthcare utilization outcomes: A meta-analysis of randomized controlled trials. Patient Education and Counseling, 100(3), 436–448. 10.1016/j.pec.2016.10.014 - DOI - PubMed
    1. Anderson JB, Martin SA, Gadomski A, Krupa N, Mullin D, Cahill A, & Jenkins P (2022). Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes. Substance Abuse, 43(1), 222–230. 10.1080/08897077.2021.1931633 - DOI - PubMed
    1. Andraka-Christou B, Randall-Kosich O, & Totaram R (2021). Designing an “ideal” substance use disorder treatment center: Perspectives of people who have utilized medications for opioid use disorder. Qualitative Health Research, 31(3), 512–522. 10.1177/1049732320971231 - DOI - PubMed

Publication types

LinkOut - more resources